Beranda › Gagal Jantung
Uji klinis Gagal Jantung yang merekrut di AS
220 studi untuk Gagal Jantung merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- New York City, NY51 studi
- Boston, MA44 studi
- Dallas, TX42 studi
- Houston, TX36 studi
- Cleveland, OH33 studi
- Chicago, IL31 studi
- Philadelphia, PA31 studi
- San Francisco, CA29 studi
- St. Louis, MO26 studi
- Durham, NC26 studi
- Atlanta, GA25 studi
- Kansas City, MO25 studi
- Baltimore, MD24 studi
- Cincinnati, OH24 studi
- San Diego, CA23 studi
- Indianapolis, IN23 studi
- Ann Arbor, MI22 studi
- Rochester, MN22 studi
- Minneapolis, MN21 studi
- Jacksonville, FL21 studi
- Los Angeles, CA20 studi
- Washington, DC19 studi
- Pittsburgh, PA19 studi
- Nashville, TN19 studi
- Tampa, FL18 studi
- Aurora, CO18 studi
- Austin, TX18 studi
- Charleston, SC18 studi
- Phoenix, AZ18 studi
- Seattle, WA17 studi
- Portland, OR17 studi
- Salt Lake City, UT17 studi
- Orlando, FL16 studi
- Richmond, VA16 studi
- Columbus, OH16 studi
- Milwaukee, WI16 studi
- Arlington, VA15 studi
- Mountain View, CA15 studi
- Miami, FL14 studi
- Harrisburg, PA14 studi
Berdasarkan negara bagian
- Alabama23 studi
- Arizona31 studi
- Arkansas11 studi
- California65 studi
- Colorado23 studi
- Connecticut21 studi
- Delaware3 studi
- Distrik Columbia12 studi
- Florida50 studi
- Georgia28 studi
- Idaho5 studi
- Illinois44 studi
- Indiana29 studi
- Iowa10 studi
- Kansas19 studi
- Kentucky21 studi
- Louisiana18 studi
- Maine6 studi
- Maryland28 studi
- Massachusetts45 studi
- Michigan37 studi
- Minnesota43 studi
- Mississippi7 studi
- Missouri40 studi
- Nebraska21 studi
- Nevada7 studi
- New Jersey27 studi
- New Mexico4 studi
- New York57 studi
- North Carolina42 studi
- Ohio55 studi
- Oklahoma17 studi
- Oregon17 studi
- Pennsylvania45 studi
- Rhode Island4 studi
- South Carolina30 studi
- South Dakota15 studi
- Tennessee33 studi
- Texas67 studi
- Utah22 studi
- Vermont8 studi
- Virginia37 studi
- Washington26 studi
- West Virginia8 studi
- Wisconsin20 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
ELEVATE-HFpEF Clinical Study
Menerima peserta
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06678841Early Feasibility Study - Edwards APTURE Transcatheter Shunt System
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT03523416Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Menerima pesertaFase 3
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06307652A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06935370Infusing Needed Iron to Target Insufficiency in Adults Treated for Evidence of Heart Failure
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07467668A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy
Menerima pesertaFase 1
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07137338A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction
Menerima pesertaFase 1
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07465653A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06424288A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
Menerima peserta
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07214376A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
Menerima pesertaFase 2
Usia 40 hingga 84 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06979362NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study
Menerima peserta
Semua usia · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT06593327Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 30 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT06517186HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 30 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT05873634A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07761117BiVACOR® Total Artificial Heart Early Feasibility Study
Menerima peserta
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06174103: Vascular Function in Health and Disease
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT02966665Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Menerima pesertaFase 3
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06736574Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07232030Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07222813A Study of LY3971297 in Participants With Heart Failure
Menerima pesertaFase 1
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07547540Tezspire Cardiac Events PASS
Menerima pesertaStudi observasional
Usia 12 hingga 130 · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT06951867Cholate Clearance in Fontan and Heart Failure
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07009132Alleviant ALLAY-HFrEF Study
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT06812533Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Menerima pesertaFase 3
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07037459Technical Development of Cardiovascular Magnetic Resonance Imaging
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT04927429Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.